Clinical Trial Update: Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating letrozole for postmenopausal women with hormone receptor-positive breast cancer after prior hormone therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN | Results posted: 2021-05-20